Clinical Trials Directory

Trials / Completed

CompletedNCT00399490

Open-label Extension Study Of RN624

OPEN-LABEL, MULTIPLE-DOSE STUDY OF THE SAFETY AND EFFICACY OF RN624 IN ADULTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
287 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basis.

Conditions

Interventions

TypeNameDescription
DRUGRN624 (PF-04383119)50 mcg/kg

Timeline

Start date
2006-09-15
Primary completion
2008-02-11
Completion
2008-02-11
First posted
2006-11-15
Last updated
2021-02-02
Results posted
2021-02-02

Locations

36 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00399490. Inclusion in this directory is not an endorsement.